Prediagnostic Blood Selenium Status and Mortality among Patients with Colorectal Cancer in Western European Populations.
cohort
colorectal cancer
selenium
selenoprotein P
survival
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
22 Oct 2021
22 Oct 2021
Historique:
received:
26
09
2021
revised:
12
10
2021
accepted:
15
10
2021
entrez:
27
11
2021
pubmed:
28
11
2021
medline:
28
11
2021
Statut:
epublish
Résumé
A higher selenium (Se) status has been shown to be associated with lower risk for colorectal cancer (CRC), but the importance of Se in survival after CRC diagnosis is not well studied. The associations of prediagnostic circulating Se status (as indicated by serum Se and selenoprotein P (SELENOP) measurements) with overall and CRC-specific mortality were estimated using multivariable Cox proportional hazards regression among 995 CRC cases (515 deaths, 396 from CRC) in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Se and SELENOP serum concentrations were measured on average 46 months before CRC diagnosis. Median follow-up time was 113 months. Participants with Se concentrations in the highest quintile (≥100 µg/L) had a multivariable-adjusted hazard ratio (HR) of 0.73 (95% CI: 0.52-1.02; P
Identifiants
pubmed: 34829750
pii: biomedicines9111521
doi: 10.3390/biomedicines9111521
pmc: PMC8614984
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 25004
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Références
Nutrients. 2013 Apr 08;5(4):1149-68
pubmed: 23567478
Epidemiology. 1996 Jul;7(4):384-90
pubmed: 8793364
Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):582-93
pubmed: 22278364
Br J Cancer. 2011 Apr 26;104(9):1493-9
pubmed: 21468044
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Nutr Cancer. 1997;28(2):165-9
pubmed: 9290123
PLoS One. 2018 Jan 5;13(1):e0184873
pubmed: 29304040
Mol Carcinog. 2000 Dec;29(4):236-50
pubmed: 11170262
Expert Rev Gastroenterol Hepatol. 2017 Aug;11(8):707-709
pubmed: 28415859
Adv Cancer Res. 2017;136:49-83
pubmed: 29054422
JAMA. 2016 Oct 11;316(14):1464-1474
pubmed: 27727382
World J Gastroenterol. 2005 Aug 7;11(29):4457-60
pubmed: 16052671
PLoS One. 2012;7(10):e46644
pubmed: 23056383
Biochem J. 2005 Mar 1;386(Pt 2):e5-7
pubmed: 15720294
J Nutr Biochem. 2008 Jan;19(1):1-7
pubmed: 17588734
Mol Cancer Ther. 2005 Aug;4(8):1239-49
pubmed: 16093440
Am J Clin Nutr. 2010 Sep;92(3):525-31
pubmed: 20573787
Br J Nutr. 2001 May;85(5):517-47
pubmed: 11348568
Am J Clin Nutr. 2010 Apr;91(4):923-31
pubmed: 20181815
Free Radic Biol Med. 2018 Nov 1;127:14-25
pubmed: 29793041
Met Ions Life Sci. 2013;13:499-534
pubmed: 24470102
Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):630-9
pubmed: 12101110
Oncotarget. 2017 Mar 21;8(12):18832-18847
pubmed: 27902968
Mol Cell Biochem. 2017 Jan;424(1-2):13-33
pubmed: 27696310
FASEB J. 2016 Aug;30(8):2812-25
pubmed: 27103578
Cochrane Database Syst Rev. 2018 Jan 29;1:CD005195
pubmed: 29376219
Free Radic Biol Med. 2018 Nov 1;127:46-54
pubmed: 29454039
J Natl Cancer Inst. 2016 Jul 06;108(11):
pubmed: 27385803
Proc Nutr Soc. 2010 Feb;69(1):119-32
pubmed: 19968907
Breast Cancer Res. 2004;6(5):R586-92
pubmed: 15318939
Nutrients. 2015 May 15;7(5):3621-51
pubmed: 25988760
Breast Cancer Res Treat. 2012 Aug;134(3):1269-77
pubmed: 22736377
Nutr Cancer. 2009;61(2):251-64
pubmed: 19235042
Stat Med. 2007 Sep 10;26(20):3735-52
pubmed: 17538974
Nutrients. 2018 Nov 21;10(11):
pubmed: 30469315
PLoS One. 2013 May 21;8(5):e63702
pubmed: 23704933
Annu Rev Nutr. 2015;35:109-34
pubmed: 25974694
Am J Clin Nutr. 2009 Jun;89(6):2025S-2039S
pubmed: 19420095
J Trace Elem Med Biol. 2019 Dec;56:46-51
pubmed: 31442953
BMC Med. 2014 Oct 10;12:168
pubmed: 25319089
Trends Biochem Sci. 2014 Mar;39(3):112-20
pubmed: 24485058
Comput Methods Programs Biomed. 2004 Apr;74(1):69-75
pubmed: 14992828
JAMA. 2009 Jan 7;301(1):39-51
pubmed: 19066370
Cancer Treat Res. 2014;159:145-66
pubmed: 24114479
Stat Med. 1989 May;8(5):551-61
pubmed: 2657958
Eur J Clin Nutr. 2004 Jan;58(1):98-104
pubmed: 14679373
Am J Pathol. 2014 Apr;184(4):1041-1049
pubmed: 24492200
Br J Nutr. 2012 May;107(10):1514-25
pubmed: 21936966
Mutagenesis. 2012 Mar;27(2):177-86
pubmed: 22294765
BMC Med. 2015 May 07;13:107
pubmed: 25948112
Breast Cancer Res Treat. 2018 Jan;167(2):591-598
pubmed: 29043463
Nat Rev Cancer. 2004 Mar;4(3):206-15
pubmed: 14993902
Mol Nutr Food Res. 2009 Dec;53(12):1561-72
pubmed: 19810021
J Biol Chem. 2001 Jun 8;276(23):20085-92
pubmed: 11274215
Inflamm Bowel Dis. 2014 Jun;20(6):1110-9
pubmed: 24694793
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Antioxid Redox Signal. 2002 Apr;4(2):339-51
pubmed: 12006185
Carcinogenesis. 2013 May;34(5):1089-95
pubmed: 23389288
Int J Cancer. 2015 Mar 1;136(5):1149-61
pubmed: 25042282
Lancet. 2012 Mar 31;379(9822):1256-68
pubmed: 22381456
Clin Colon Rectal Surg. 2009 Nov;22(4):191-7
pubmed: 21037809